Tumour infiltrating B cells have been observed in a growing number of cancer types and likely interact with T cells in both secondary lymphoid tissues and tumour tissue.1 Recent interest has focussed on B cells as a candidate for CD4+ T cell-based cellular vaccine approaches. The gene discussed is CD4; the disease is cancer.